Vimarsana
Biggest News Aggregation in the World

Page 39 - Life Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Technologies Today - Breaking & Trending Today

Primmune Therapeutics Strengthens Leadership Team with Key Appointments - Vimarsana News

Primmune Therapeutics Strengthens Leadership Team with Key Appointments

Published: Feb 05, 2021 SAN DIEGO--(BUSINESS WIRE)-- Today, Primmune Therapeutics announced the appointment of Rich Daniels as Chief Operating Officer, Scott Zook as Senior Vice President, Global Manufacturing and Randy Adams as Senior Advisor, Commercial Development. “The appointments of Rich, Scott and Randy to the team build on the recent close of our Series A financing to support the development of PRTX007 as a therapeutic-adjuvant for viral diseases and cancer,” said Charlie McDermott, Chairman and Chief Executive Officer of Primmune Therapeutics. “Rich, Scott, and Randy have v...

Berkeley Lights Announces CFO Transition and C-Level Additions - Vimarsana News

Berkeley Lights Announces CFO Transition and C-Level Additions

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Berkeley Lights Announces CFO Transition and C-Level Additions Berkeley Lights, IncFebruary 4, 2021 GMT Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights Company to Report Fourth Quarter and Year-End 2020 Financial Results on February 25, 2021 EMERYVILLE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, announced today the following organizational updates: Kurt Wood, currently t...

Source: apnews.com
ZQ Capital Sells Surgical Specialties for About $800 Million - Vimarsana News

ZQ Capital Sells Surgical Specialties for About $800 Million

ZQ Capital Sells Surgical Specialties for About $800 Million Bloomberg 2/1/2021 © Bloomberg Surgical tools are seen on display in Germany. (Bloomberg) -- China-focused private equity firm ZQ Capital sold a U.S. medical device manufacturer to buyout firm GTCR for about $800 million including debt, people familiar with the matter said. A consortium led by ZQ Capital, founded by a pair of former Barclays Plc and JPMorgan Chase & Co. bankers, and Vivo Capital sold Surgical Specialties Corp., according to a release on Monday, which didn’t give the transaction value. A representative for ZQ...

Source: msn.com
Dr. Siddhartha Kadia to Join NuVasive Board of Directors - Vimarsana News

Dr. Siddhartha Kadia to Join NuVasive Board of Directors

Share this article Share this article SAN DIEGO, Feb. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Siddhartha Kadia, Ph.D. to the Company's Board of Directors, effective February 1, 2021. Dr. Kadia has more than 20 years of experience in the medical technology industry with expertise in globally commercializing disruptive technology. He most recently served as president and CEO of EAG Laboratories, a global...

Sequencing Reagents Kits Market Booming Demand Leading To Exponential CAGR Growth By 2027 – KSU - Vimarsana News

Sequencing Reagents Kits Market Booming Demand Leading To Exponential CAGR Growth By 2027 – KSU

Databridgemarketresearch.com Present “ Sequencing Reagents Kits Market – Industry Trends and Forecast to 2027” new report to its research database. The research report released by Data Bridge Market research provides the market segmentation based on type, market size, Product launches and applications. It identifies the global adoption of the products as one of the growth factors, driven by the availability of the product. The global research report gives the brief summary of the leading players operating in the market, their product offering, key developments, investments feasibility a...